Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-08CRNX144JEFF KNIGHT plan to sell securities of CRINETICS PHARMACEUTICALS INC under Form 144MEDIUM
JEFF KNIGHT filed Form 144 to notify SEC of plan to sell 85163 units of CRINETICS PHARMACEUTICALS INC securities around 2026-04-08, with aggregate market value of $3,271,110.83. The total outstanding units is 104705330.0. The amount planned to be sold represents 0.08% of total outstanding units; Recent transactions in ...
Mid CapBiotechnology
2026-04-08DNA144Kelly Jason R plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144MEDIUM
Kelly Jason R filed Form 144 to notify SEC of plan to sell 97015 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-04-08, with aggregate market value of $672,343.05. The total outstanding units is 49941878.0. The amount planned to be sold represents 0.19% of total outstanding units; ...
Small CapBiotechnology
2026-04-08RCUS144JENNIFER JARRETT plan to sell securities of ARCUS BIOSCIENCES, INC. under Form 144MEDIUM
JENNIFER JARRETT filed Form 144 to notify SEC of plan to sell 70000 units of ARCUS BIOSCIENCES, INC. securities around 2026-04-08, with aggregate market value of $1,579,592.00. The total outstanding units is 125349476.0. The amount planned to be sold represents 0.06% of total outstanding units; ...
Mid CapBiotechnology